Skip directly to content

10 причин вибрати Династат

ПЕРШИЙ і ЄДИНИЙ ін'єкційний парекоксиб в Україні


1. Malan TP, Gordon S. The Cylooxygenase-2-Speci c Inhibitor Parecoxib Sodium Is as E active as 12mg of Morphine Administered
Intramuscularly for Treating Pain After Gynecologic Laparotomy Surgery. Anesth Analg. 2005;100: 454-460.
2. Інструкція для медичного застосування  ДИНАСТАТ. РП № UA/2286/01/02, UA/2525/01/01 від 03.11.2009, 17.10.14, 19.08.2015 
3. Adapted from Noveck R.J., Laurent A., Kuss M. et al. Parecoxib Sodium does not Impair Platelet Function in Healthy Elderly and Non-Elderly Individuals. Two randomized, controlled trials. Clin Drug Invest. 2001;21(7):465-476.
4. Adapted from: Hubbard R.C., Naumann T.M., Traylor L. et al. Parecoxib sodium has opioid-sparing acts in patients undergoing total knee arthroplasty under spinal anesthesia. Br J Anaesth. 2003;90:166-172.
5. Peng M., Wang Y-L., Wang F.F. at al. The cyclooxygenase-2 inhibitor parecoxib inhibits surgery-induced proin ammatory cytokine expression in the hippocampus in aged rats. Journal of surgical
research 2012; 178:E1-E8.
6. Adapted from Harris S.I., Stoltz R.R., LeComte D. et al. Parecoxib sodium demonstrates Gastrointestinal safety comparable to placebo in healthy subjects. J Clin Gastroenterol. 2004;38(7):575-580.
7. J.N.Cote, M.K.Hoeger Bement. Update on the relation between pain and movement:consequences for clinical practice.Clin J Pain.2010;26(9): 754-762.